What is ALHC's health score?

Alignment Healthcare, Inc. (ALHC) has a TradeApes health score of 63 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ALHC's estimated fair value?

Based on our 5-year discounted cash flow model, Alignment Healthcare, Inc.'s estimated fair value is $1.81 per share, representing a -88.2% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is ALHC undervalued or overvalued?

Our model currently rates ALHC as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ALHC... Refresh in a moment for the full analysis.

Alignment Healthcare, Inc. (ALHC)

Financials Overvalued medium healthy

$15.36

Updated: 2026-06-05

TradeApes Score

Financial Strength

70 Healthy

Operating Trend

75 Strong

Relative Value

55 Mixed

Capital Allocation

35 Weak

Risk

80 Strong

Est. Fair Value $1.81

DCF Upside -88.2%

Sector Rank #135 of 6311

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.